venlafaxine hydrochloride has been researched along with Sensitivity and Specificity in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 16 (51.61) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, T; Li, L; Lin, M; Qian, M; Shen, X; Shen, Z; Yang, J; Yuan, Y | 1 |
| Bakhtiar, R; Black, M; Cookson, C; Fiorella, A; Gorman, SH; Gu, G; Li, Y | 1 |
| Dziurkowska, E; Wesolowski, M | 1 |
| Berm, EJ; Brummel-Mulder, E; Hak, E; Maring, JG; Paardekooper, J; Wilffert, B | 1 |
| Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Novak, T; Sos, P; Stopkova, P | 1 |
| Eliasson, E; Haslemo, T; Lindh, JD; Mannheimer, B; Molden, E | 1 |
| Arns, M; Boutros, NN; Gordon, E | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Concheiro, M; Cruz, A; de Castro, A; López-Rivadulla, M; Quintela, O | 1 |
| Li, XY; Meng, J; Qin, XY; Sun, XL; Wen, AD; Zhou, J | 1 |
| Arneth, B; Härtter, S; Hiemke, C; Shams, M | 1 |
| Li, F; Li, N; Qin, F; Qin, T; Zhang, Y | 1 |
| Baker, DR; Kasprzyk-Hordern, B; Kondakal, VV | 1 |
| Kourti, PV; Samanidou, VF | 1 |
| Hasselstrøm, J | 1 |
| Dai, YC; Deng, N; Liu, W; Liu, XR | 1 |
| Ahmad, SI; Dutta, L; Khuroo, A; Mishra, S; Monif, T; Mukherjee, SK | 1 |
| Conca, A; König, P; Moll, W; Waschgler, R | 1 |
| Huande, L; Juan, H; Zhiling, Z | 1 |
| Li, HD; Liu, W; Wang, F | 1 |
| Cai, HL; Li, HD; Liu, W | 1 |
| Bing-Ren, X; Cai-Yun, W; Wei, Z | 1 |
| Nageswara Rao, R; Narasa Raju, A | 1 |
| Amore, M; Cesta, R; Fanali, S; Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
| Patel, BN; Sanyal, M; Sharma, N; Shrivastav, PS | 1 |
| Albers, L; Helmeste, D; Reist, C; Vu, RL | 1 |
| Clement, EM; Franklin, M; Odontiadis, J | 1 |
| Balant-Gorgia, AE; Fanali, S; Rudaz, S; Stella, C; Veuthey, JL | 1 |
| Desiderio, C; Fanali, S; Rudaz, S; Veuthey, JL | 1 |
| Dumora, F; Jarry, C; Matoga, M; Pehourcq, F; Titier, K | 1 |
| Cherkaoui, S; Rudaz, S; Varesio, E; Veuthey, JL | 1 |
1 review(s) available for venlafaxine hydrochloride and Sensitivity and Specificity
| Article | Year |
|---|---|
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
2 trial(s) available for venlafaxine hydrochloride and Sensitivity and Specificity
| Article | Year |
|---|---|
QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Computer-Assisted; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Reproducibility of Results; Sensitivity and Specificity; Theta Rhythm; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Electroencephalography; Female; Humans; Internationality; Male; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
28 other study(ies) available for venlafaxine hydrochloride and Sensitivity and Specificity
| Article | Year |
|---|---|
Early improvement predicts 8-week treatment outcome in patients with generalized anxiety disorder treated with escitalopram or venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Sensitivity and Specificity; Time Factors; Venlafaxine Hydrochloride | 2017 |
Validation of an LC-MS/MS method for simultaneous quantification of venlafaxine and its five metabolites in rat plasma and its application in a pharmacokinetic study.
Topics: Animals; Chromatography, Liquid; Drug Stability; Female; Linear Models; Rats; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2018 |
Simultaneous quantitation of venlafaxine and its main metabolite, O-desmethylvenlafaxine, in human saliva by HPLC.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Male; Saliva; Sensitivity and Specificity; Venlafaxine Hydrochloride | 2013 |
Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dried Blood Spot Testing; Drug Monitoring; Humans; Sensitivity and Specificity; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2014 |
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Paliperidone Palmitate; Predictive Value of Tests; Retrospective Studies; Risperidone; Sensitivity and Specificity; Venlafaxine Hydrochloride; Young Adult | 2016 |
LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.
Topics: Antidepressive Agents; Chromatography, Liquid; Cyclohexanols; Female; Humans; Male; Reproducibility of Results; Saliva; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors; Venlafaxine Hydrochloride | 2008 |
Determination of venlafaxine in human plasma by high-performance liquid chromatography using cloud-point extraction and spectrofluorimetric detection.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 2008 |
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; DNA Mutational Analysis; Female; Gene Duplication; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Sequence Deletion; Venlafaxine Hydrochloride | 2009 |
Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Ether; Humans; Linear Models; Male; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2010 |
Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry.
Topics: Amphetamines; Chromatography, Liquid; Cyclohexanols; Illicit Drugs; Linear Models; Propanolamines; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Waste Products; Water Pollutants, Chemical | 2010 |
Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Duloxetine Hydrochloride; Fluoxetine; Humans; Limit of Detection; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.
Topics: Antidepressive Agents; Antipsychotic Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dibenzothiazepines; Humans; Methanol; Mianserin; Mirtazapine; Piperazines; Quetiapine Fumarate; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Venlafaxine Hydrochloride; Zinc Sulfate | 2011 |
Development and validation of a HPLC-MS/MS method for the determination of venlafaxine enantiomers and application to a pharmacokinetic study in healthy Chinese volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; China; Chromatography, High Pressure Liquid; Cyclohexanols; Drug Stability; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Tandem Mass Spectrometry; Vancomycin; Venlafaxine Hydrochloride; Young Adult | 2011 |
Liquid chromatography tandem mass spectrometry method for the simultaneous stereoselective determination of venlafaxine and its major metabolite, O-desmethylvenlafaxine, in human plasma.
Topics: Acetates; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Male; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Tandem Mass Spectrometry; Temperature; Venlafaxine Hydrochloride | 2013 |
Quantification of venlafaxine and O-desmethylvenlafaxine in human serum using HPLC analysis.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cost-Benefit Analysis; Cyclohexanols; Desvenlafaxine Succinate; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Venlafaxine Hydrochloride | 2004 |
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2005 |
Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Vancomycin; Venlafaxine Hydrochloride | 2007 |
High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
Topics: Antidepressive Agents, Second-Generation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Female; Humans; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2007 |
Liquid chromatography-mass spectrometry method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study.
Topics: Adolescent; Adult; Area Under Curve; Chromatography, High Pressure Liquid; Chromatography, Liquid; Clozapine; Cyclohexanols; Drug Stability; Humans; Male; Plasma; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2007 |
Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Sensitivity and Specificity; Spectroscopy, Fourier Transform Infrared; Temperature; Venlafaxine Hydrochloride | 2006 |
Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 2007 |
Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.
Topics: Area Under Curve; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Humans; Sensitivity and Specificity; Tandem Mass Spectrometry; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2008 |
Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Circadian Rhythm; Cyclohexanols; Desvenlafaxine Succinate; Humans; Linear Models; Osmolar Concentration; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 1997 |
Simultaneous measurement of venlafaxine and its major metabolite, oxydesmethylvenlafaxine, in human plasma by high-performance liquid chromatography with coulometric detection and utilisation of solid-phase extraction.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Paroxetine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Venlafaxine Hydrochloride | 1998 |
Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins.
Topics: Antidepressive Agents, Second-Generation; Cyclodextrins; Cyclohexanols; Desvenlafaxine Succinate; Electrophoresis, Capillary; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Venlafaxine Hydrochloride | 2000 |
Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Micellar Electrokinetic Capillary; Cyclohexanols; Desvenlafaxine Succinate; Sensitivity and Specificity; Silicon Dioxide; Stereoisomerism; Vancomycin; Venlafaxine Hydrochloride | 2001 |
Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2001 |
On-line capillary electrophoresis-electrospray mass spectrometry for the stereoselective analysis of drugs and metabolites.
Topics: Amphetamines; Cyclodextrins; Cyclohexanols; Electrophoresis, Capillary; Indicators and Reagents; Methadone; Pharmaceutical Preparations; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tropanes; Venlafaxine Hydrochloride | 2001 |